Home・Listă Acțiuni・Pacific Biosciences of California Inc

Pacific Biosciences of California Inc

Închisă

SectorSănătate

1.14

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

1.12

Maxim

1.17

Indicatori cheie
By Trading Economics
Venit	-45M -53M
Vânzări	1.8M 39M
EPS	-0.14
Marjă de profit	-135.914
Angajați	485
EBITDA	-37M -43M

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+132.17% upside

Dividende
By Acuity
Următoarele câștiguri	4 nov. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	-84M 357M
Deschiderea anterioară	1.14
Închiderea anterioară	1.14

Sentimentul știrilor

By Acuity

50%

163 / 340 Clasament în Healthcare

Pacific Biosciences of California Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

14 aug. 2026, 19:36 UTC

Correlated Moves

News

Pacific Biosciences reported second-quarter revenue of $39.01 million, missing estimates. Shares are trading lower amid concerns over funding constraints and adoption challenges.

13 aug. 2026, 23:06 UTC

Correlated Moves

Pacific Biosciences of California Inc. gained modestly in after-market trading, reflecting broader market trends seen in correlated assets.

12 aug. 2026, 23:41 UTC

Pacific Biosciences shares are lower in after-market hours, trading below their 20-day moving average amid easing inflation concerns and broader market conditions.

11 aug. 2026, 20:06 UTC

Pacific Biosciences of California is trading higher in a routine session. The stock remains below its 20-day moving average despite today's gains.

10 aug. 2026, 23:21 UTC

Pacific Biosciences of California Inc. shares are higher in after-market trading, recovering from earlier losses and gaining since Monday's close.

7 aug. 2026, 22:56 UTC

Correlated Moves

Pacific Biosciences shares are lower in after-market trading, retracing from an initial gain as 10X Genomics declines, impacting market sentiment.

6 aug. 2026, 23:11 UTC

Pacific Biosciences of California is higher in after-market trading, reflecting positive momentum since Thursday's close, despite being below its 20-day moving average.

5 aug. 2026, 23:01 UTC

News

Pacific Biosciences reported lower second-quarter revenue and a wider EPS loss, prompting a reduction in full-year sales guidance. Shares are down in after-market trading.

4 aug. 2026, 21:36 UTC

Pacific Biosciences of California remained roughly flat after market hours. Broader market gains were driven by a decline in crude oil prices.

3 aug. 2026, 23:36 UTC

Pacific Biosciences of California Inc. shares are roughly flat after-market, remaining near the lower end of their one-month trading range.

31 iul. 2026, 19:46 UTC

News

Correlated Moves

Pacific Biosciences of California is trading lower amid a report citing annual sales declines and cash burn concerns impacting its growth outlook.

29 iul. 2026, 16:06 UTC

Correlated Moves

Pacific Biosciences of California Inc shares are lower today, reflecting broader market pressure on small-cap equities and a notable decline in correlated assets.

28 iul. 2026, 16:12 UTC

Pacific Biosciences is trading higher, rebounding from earlier losses despite broader market caution following declines in the Nikkei 225 Index.

27 iul. 2026, 19:06 UTC

Pacific Biosciences is trading higher as the broader market rises, supported by a notable decline in crude oil prices that has eased geopolitical tensions.

24 iul. 2026, 22:31 UTC

Pacific Biosciences shares are higher in after-market trading. No specific company news was identified to explain this movement.

22 iul. 2026, 18:01 UTC

Correlated Moves

Pacific Biosciences of California shares are lower amid broader market pressures and rising crude oil prices, trading below its 20-day moving average.

21 iul. 2026, 13:01 UTC

Pacific Biosciences is rallying in pre-market trading, continuing its upward trend since Monday's close after three sessions of declines. No specific news was identified.

20 iul. 2026, 23:01 UTC

Shares of Pacific Biosciences of California are higher in after-market hours, marking a peak cumulative return since Monday's close amid broader market volatility.

Comparație

Modificare preț

Pacific Biosciences of California Inc Așteptări

Obiectiv de preț

By TipRanks

132.17% sus

Prognoză pe 12 luni

Medie 2.67 USD 132.17%

Maxim 3 USD

Minim 2 USD

În baza a 3 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPacific Biosciences of California Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

3 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 3 analiști care au acordat evaluări ale acțiunilor Pacific Biosciences of California Inc - Dist în ultimele 3 luni.

Sentiment

By Acuity

163 / 340 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Pacific Biosciences of California Inc

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.